Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A

Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition

(2014) P Chaudhry et al.   Cell Death & Disease

Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4

(2014) Ravshan Burikhanov et al.   Cell Reports

Changes in Mouse Uterine Transcriptome in Estrus and Proestrus1

(2013) Kerri Stanley Yip et al.   BIOLOGY OF REPRODUCTION

Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma

(2013) Subhasis Barik et al.   PLoS One

ETS-1 Protein Regulates Vascular Endothelial Growth Factor-induced Matrix Metalloproteinase-9 and Matrix Metalloproteinase-13 Expression in Human Ovarian Carcinoma Cell Line SKOV-3

(2012) Sonali Ghosh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Activation Status of Wnt/ß-Catenin Signaling in Normal and Neoplastic Breast Tissues: Relationship to HER2/neu Expression in Human and Mouse

(2012) Sara Khalil et al.   PLoS One

A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4

(2012) Bilal Rah et al.   PLoS One

Prostate Apoptosis Response 4 (Par-4), a Novel Substrate of Caspase-3 during Apoptosis Activation

(2011) P. Chaudhry et al.   MOLECULAR AND CELLULAR BIOLOGY

Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential

(2011) Syed Khalid Yousuf et al.   STEROIDS

Cancer-selective apoptotic effects of extracellular and intracellular Par-4

(2010) T Shrestha-Bhattarai et al.   ONCOGENE

Expression of Prostate Apoptosis Response (Par-4) Is Associated with Progesterone Receptor in Breast Cancer

(2009) Pablo Zapata-Benavides et al.   ARCHIVES OF MEDICAL RESEARCH

Lupeol inhibits proliferation of human prostate cancer cells by targeting  -catenin signaling

(2009) M. Saleem et al.   CARCINOGENESIS

Targeting CYP17: established and novel approaches in prostate cancer

(2008) Timothy A Yap et al.   CURRENT OPINION IN PHARMACOLOGY

Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis

(2008) Jayashree Joshi et al.   EMBO JOURNAL